FDA Faces 1,300+ Staffing Gap as Pharma Regulatory Delays Mount
NewsData.io · United States · Nov 11, 2026
The FDA's drug and biologics divisions are operating with 1,343 fewer employees than a year ago across CBER and CDER, following mass departures, layoffs, and early retirement offers in 2025. The agency had a hiring target of roughly 2,200 open positions as of June, but qualified candidates are being deterred by past abrupt firings and HR bottlenecks slowing onboarding. Drug developers report more inconsistent FDA reviews, communication breakdowns, and slower informal feedback channels. Staffing firms with life sciences and regulatory affairs specialties may see increased demand as pharma companies seek external expertise to navigate the FDA's reduced capacity.
Get the weekly brief by email
What changed in staffing last week, every Monday morning. Free. Unsubscribe anytime.
Related stories
A Baltimore Sun analysis finds Maryland reduced average teacher vacancies per district from 90.4 in 2022-23 to 36.9 in 2025-26, with teacher headcount…
Healthcare workers at Connecticut Department of Correction facilities rallied in Hartford Wednesday, citing extreme understaffing — including just two…
BGSF reported Q3 2026 revenue of $25.1 million, down 6.6% year over year, as high interest rates and cost discipline among property owners reduced…
Sheriff's offices in rural Texas are reporting an average vacancy rate of 28.2% — the highest of any law enforcement agency type in the state …